Arizona State Retirement System Cyma Bay Therapeutics, Inc. Transaction History

Arizona State Retirement System

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$12.63 - $24.47 $2,071 - $4,013	-164 Reduced 0.74%	22,048 $520,000
Q3 2023 Nov 06, 2023	BUY	$10.86 - $17.62 $18,635 - $30,235	1,716 Added 8.37%	22,212 $331,000
Q2 2023 Aug 01, 2023	SELL	$7.47 - $10.95 $30,178 - $44,238	-4,040 Reduced 16.47%	20,496 $224,000
Q1 2023 Apr 27, 2023	BUY	$5.88 - $9.59 $144,271 - $235,300	24,536 New	24,536 $213,000
Q2 2021 Aug 02, 2021	SELL	$3.94 - $4.92 $55,305 - $69,062	-14,037 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$4.23 - $6.55 $219 - $340	52 Added 0.37%	14,037 $64,000
Q4 2020 Jan 28, 2021	BUY	$5.73 - $9.03 $80,134 - $126,284	13,985 New	13,985 $80,000
Q2 2020 Aug 04, 2020	SELL	$1.41 - $4.25 $20,467 - $61,693	-14,516 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$1.25 - $2.02 $18,145 - $29,322	14,516 New	14,516 $21,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.